Cargando…
Assessing the role of rare genetic variants in drug‐resistant, non‐lesional focal epilepsy
OBJECTIVE: Resistance to antiseizure medications (ASMs) is one of the major concerns in the treatment of epilepsy. Despite the increasing number of ASMs available, the proportion of individuals with drug‐resistant epilepsy remains unchanged. In this study, we aimed to investigate the role of rare ge...
Autores principales: | Wolking, Stefan, Moreau, Claudia, McCormack, Mark, Krause, Roland, Krenn, Martin, Berkovic, Samuel, Cavalleri, Gianpiero L., Delanty, Norman, Depondt, Chantal, Johnson, Michael R., Koeleman, Bobby P. C., Kunz, Wolfram S., Lerche, Holger, Marson, Anthony G., O’Brien, Terence J., Petrovski, Slave, Sander, Josemir W., Sills, Graeme J., Striano, Pasquale, Zara, Federico, Zimprich, Fritz, Sisodiya, Sanjay M., Girard, Simon L., Cossette, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283173/ https://www.ncbi.nlm.nih.gov/pubmed/34018700 http://dx.doi.org/10.1002/acn3.51374 |
Ejemplares similares
-
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
por: Wolking, Stefan, et al.
Publicado: (2021) -
Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019) -
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
por: Campbell, Ciarán, et al.
Publicado: (2022) -
A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019) -
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin
por: Boothman, Isabelle, et al.
Publicado: (2023)